Additionally, studies in patients with T2DM are now needed to explore potential clinical benefits [197]
New Research Links GLP-1 Agonists to NAION A study published in JAMA Ophthalmology on July 3, 2024, found that type 2 diabetes patients prescribed GLP-1 agonists were at an increased risk for developing a rare and debilitating eye condition called NAION
The female mice (homozygous for Hba tm1(HBA)Tow and heterozygous for Hbb tm2(HBG1,HBB*)Tow and Hbb tm3(HBG1,HBB)Tow [h/h:: A / S ], sickle-cell trait mice) and male mice (homozygous for both Hba tm1(HBA)Tow and Hbb tm2(HBG1,HBB*)Tow [h/h:: S / S ], sickle SCD mice) were bred to generate SCD mice
The long-term costs associated with obesity-related comorbidities justify consideration of more expensive interventions if they prove effective
Personalization through genetics removes guessworkyour dose may need to go up, but your price won'tensuring you receive the most effective medication for your body's unique biology
I did this talk on the different types of belching that actually went viral, he shares